Market Analysis

The US Chamber of Commerce and Pugatch Consilium’s Dr David Torstensson launch 2nd edition of the GIPC IP Index

Posted by:

Dr David Torstensson, Partner with Pugatch Consilium, is speaking at the international launch of the 2013 GIPC IP Index at the US Chamber of Commerce in Washington DC, USA. Pugatch Consilium has developed the GIPC IP Index in partnership with the US Chamber of Commerce’s Global Intellectual Property Center. The Index is a one-of-a-kind instrument that benchmarks and measures the national IP environment in 25 countries.

The launch of the 2013 Index will take place on January 29 2014 starting at ...

Continue Reading →
0

Pugatch Consilium at the World Creators Summit, June 4-5 2013 Washington DC

Posted by:

Dr David Torstensson, Senior Consultant with Pugatch Consilium, is attending the 2013 World Creators Summit in Washington DC, USA. Dr Torstensson is co-authoring a study of the creative economy in Brazil, Russia, India, China and South Africa commissioned by the International Confederation of Societies of Authors and Composers (CISAC) and is due for publication later this summer. He will be discussing the initial findings from this study at the World Creators Summit.

Dr Torstensson will be speaking on June 4th 2013 ...

Continue Reading →
0

Launch of new global survey and index by Pugatch Consilium

Posted by:

The Pugatch Consilium has launched a new global survey of biopharmaceutical executives on countries’ competitiveness for investment.

The objective of the Biopharmaceutical Competitiveness and Investment (BCI) Survey is to provide a comprehensive snapshot of different countries’ attractiveness for biopharmaceutical investment, derived from the firsthand knowledge of executives and experts operating in each country. Using statistical analysis, respondents’ answers are translated into a quantitative index or score, which is then used to rank countries and benchmark their performance vis à vis other countries. Ultimately, ...

Continue Reading →
0

The battle down under becomes global – how far reaching is the impact of Australia’s new plain packaging law?

Posted by:

Tobacco companies are challenging  the constitutionality of a law banning the display of their logos and designs on cigarette packs in Australia’s High Court. Their argument is that by appropriating valuable property – the trademarks which identify and distinguish their products – without compensating them, the government is ‘unjustly’ acquiring property. The debate has already expanded beyond Australia; the UK and New Zealand are also considering similar laws. More broadly, the important question is how such a law – which ...

Continue Reading →
0

A happy marriage?

Posted by:

China is the lead exporter of solar panels, and the US the leading supplier of the prime ingredient polysilicon – should be a happy marriage, right?

It could be if governments would step away and let sectors with competitive advantages be truly competitive. Instead, the US Commerce Department is claiming the Chinese government subsidises the export of its solar panels and China of course points to the failure of US-backed solar panel manufacturer Solyndra. Now the Chinese industry may retaliate with its ...

Continue Reading →
0

On numbers and access to medicines

Posted by:

Will the proposed Preserve Access to Affordable Generics (PGGA) Act actually generate the $4.8 billion savings over 10 years that the Congressional Budget Office suggests it will? How realistic are its assumptions about generic competition or healthcare costs over the next ten years?

The CBO’s savings estimate of a new bill restricting the use of patent settlement agreements which reward generic manufacturers for delaying market entry and avoid litigation under the ANDA approval pathway is exaggerated. It assumes that savings from ...

Continue Reading →
0
Page 5 of 5 12345